DYN
Dyne Therapeutics Inc
Price:  
29.50 
USD
Volume:  
469,452.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DYN Probability of Bankruptcy

The Probability of Bankruptcy of Dyne Therapeutics Inc (DYN) is 4.62% . This number represents the probability that DYN will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating DYN's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

DYN - ESG ratings

ESG ratings are directly linked to the cost of capital and DYN's ability to raise funding, both of which can significantly affect the probability of Dyne Therapeutics Inc going bankrupt.

ESG Score 57.43
Environment Score 56.41
Social Score 99.00
Governance Score 16.89
Returns
Historical Returns (5 day) 1.77%
Historical Returns (MTD) -6.34%
Historical Returns (YTD) 115.56%
Historical Returns (13 week) -11.70%
Historical Returns (26 week) -12.83%
Historical Returns (52 week) 156.44%
Efficiency
Asset Turnover
Receiveable Turnover
Gross Margin
Operating Margin
Pretax Margin
Net Margin
Return on Asset (ROA) -51.62
Return on Equity (ROE) -57.46
Return on Investments (ROI) -57.46
Price Metrics
Market Cap (M) 3,002.22
Enterprise Value (M)
52 Week High 47.45
52 Week Low 10.38
Beta 1.77
Average Volume (10 day) 0.88
Average Volume (3 month) 1.19
Price / Earnings (P/E)
Price / Sales (P/S)
Earnings
EPS -3.56
Revenue CAGR (5 year)
Risk
Current Ratio 17.02
Quick Ratio 16.73